Similar articles for PMID: 29674421

Year	Number of Results
1985	1
1987	2
1989	2
1990	2
1991	1
1992	3
1993	1
1994	2
1995	1
1997	4
1998	3
1999	3
2000	1
2001	1
2003	9
2004	7
2005	6
2006	6
2007	9
2008	5
2009	8
2010	7
2011	10
2012	14
2013	13
2014	13
2015	10
2016	13
2017	14
2018	15
2019	22
2020	21
2021	21
2022	17
2023	8
2024	0

1

Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.

Deshayes E, Ladjohounlou R, Le Fur P, Pichard A, Lozza C, Boudousq V, Sevestre S, Jarlier M, Kashani R, Koch J, Sosabowski J, Foster J, Chouin N, Bruchertseifer F, Morgenstern A, Kotzki PO, Navarro-Teulon I, Pouget JP. Deshayes E, et al. J Nucl Med. 2018 Aug;59(8):1234-1242. doi: 10.2967/jnumed.118.208611. Epub 2018 Apr 19. J Nucl Med. 2018. PMID: 29674421 Free article.

2

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.

Kersual N, Garambois V, Chardès T, Pouget JP, Salhi I, Bascoul-Mollevi C, Bibeau F, Busson M, Vié H, Clémenceau B, Behrens CK, Estupina P, Pèlegrin A, Navarro-Teulon I. Kersual N, et al. MAbs. 2014;6(5):1314-26. doi: 10.4161/mabs.29316. MAbs. 2014. PMID: 25517316 Free PMC article.

3

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.

Grünberg J, Lindenblatt D, Dorrer H, Cohrs S, Zhernosekov K, Köster U, Türler A, Fischer E, Schibli R. Grünberg J, et al. Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1907-15. doi: 10.1007/s00259-014-2798-3. Epub 2014 May 24. Eur J Nucl Med Mol Imaging. 2014. PMID: 24859811

4

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. Brouwers AH, et al. J Nucl Med. 2004 Feb;45(2):327-37. J Nucl Med. 2004. PMID: 14960657 Free article.

5

Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to ¹¹¹In and ¹⁷⁷Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer.

Aghevlian S, Lu Y, Winnik MA, Hedley DW, Reilly RM. Aghevlian S, et al. Mol Pharm. 2018 Mar 5;15(3):1150-1159. doi: 10.1021/acs.molpharmaceut.7b01000. Epub 2018 Jan 30. Mol Pharm. 2018. PMID: 29314858

6

Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [⁶⁴Cu]Cu-NOTA-panitumumab F(ab')₂ alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib.

Boyle AJ, Cao PJ, Cai Z, Chan C, Hedley DW, Reilly RM. Boyle AJ, et al. Nucl Med Biol. 2020 May-Jun;84-85:46-54. doi: 10.1016/j.nucmedbio.2020.02.001. Epub 2020 Feb 3. Nucl Med Biol. 2020. PMID: 32062317

7

177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.

Liu Z, Ma T, Liu H, Jin Z, Sun X, Zhao H, Shi J, Jia B, Li F, Wang F. Liu Z, et al. Mol Pharm. 2014 Mar 3;11(3):800-7. doi: 10.1021/mp4005047. Epub 2014 Feb 3. Mol Pharm. 2014. PMID: 24472064

8

Evaluation of [¹³¹I]I- and [¹⁷⁷Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer.

Tsai WK, Zettlitz KA, Dahlbom M, Reiter RE, Wu AM. Tsai WK, et al. Mol Imaging Biol. 2020 Oct;22(5):1380-1391. doi: 10.1007/s11307-020-01518-4. Mol Imaging Biol. 2020. PMID: 32661830 Free PMC article.

9

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, van Dongen GA. Perk LR, et al. J Nucl Med. 2005 Nov;46(11):1898-906. J Nucl Med. 2005. PMID: 16269605 Free article.

10

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.

Heskamp S, Hernandez R, Molkenboer-Kuenen JDM, Essler M, Bruchertseifer F, Morgenstern A, Steenbergen EJ, Cai W, Seidl C, McBride WJ, Goldenberg DM, Boerman OC. Heskamp S, et al. J Nucl Med. 2017 Jun;58(6):926-933. doi: 10.2967/jnumed.116.187021. Epub 2017 Feb 23. J Nucl Med. 2017. PMID: 28232604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

242 results

Results by year